NASDAQ | ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index.
The index is designed to provide exposure toU. S. companies comprising the pharmaceutical sector that have been selected based upon their liquidity and ranking.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 7.91% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 7.06% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 6.87% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 6.72% |
| BMY | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 6.60% |
| UTHR | United Therapeutics Corporation | Healthcare | Biotechnology | 4.60% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 4.15% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.05% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.81% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 3.69% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 3.66% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.38% |
| VTRS | Viatris Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.29% |
| ZTS | Zoetis Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.13% |
| OGN | Organon & Co | Healthcare | Drug Manufacturers - General | 3.04% |
| CAH | Cardinal Health Inc | Healthcare | Medical Distribution | 3.00% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.80% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 1.91% |
| HALO | Halozyme Therapeutics Inc | Healthcare | Biotechnology | 1.64% |
| MEDP | Medpace Holdings Inc | Healthcare | Diagnostics & Research | 1.32% |